{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T12:20:20Z","timestamp":1789906820073,"version":"4.0.1"},"reference-count":67,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,7,22]],"date-time":"2021-07-22T00:00:00Z","timestamp":1626912000000},"content-version":"vor","delay-in-days":202,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["DK125272"],"award-info":[{"award-number":["DK125272"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","cmghjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cellular and Molecular Gastroenterology and Hepatology"],"published-print":{"date-parts":[[2021]]},"DOI":"10.1016\/j.jcmgh.2021.07.012","type":"journal-article","created":{"date-parts":[[2021,7,27]],"date-time":"2021-07-27T05:54:40Z","timestamp":1627365280000},"page":"1517-1529","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["Therapeutic Potential for CFTR Correctors in Autosomal Recessive Polycystic Kidney Disease"],"prefix":"10.1016","volume":"12","author":[{"given":"Murali K.","family":"Yanda","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vartika","family":"Tomar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4362-8995","authenticated-orcid":false,"given":"Liudmila","family":"Cebotaru","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jcmgh.2021.07.012_bib1","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1038\/ng833","article-title":"The gene mutated in autosomal recessive polycystic kidney disease encodes a large, receptor-like protein","volume":"30","author":"Ward","year":"2002","journal-title":"Nat Genet"},{"key":"10.1016\/j.jcmgh.2021.07.012_bib2","doi-asserted-by":"crossref","first-page":"2246","DOI":"10.1097\/01.ASN.0000030392.19694.9D","article-title":"Identification and characterization of Pkhd1, the mouse orthologue of the human ARPKD gene","volume":"13","author":"Nagasawa","year":"2002","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.jcmgh.2021.07.012_bib3","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1007\/s00441-006-0226-0","article-title":"Molecular and cellular pathophysiology of autosomal recessive polycystic kidney disease (ARPKD)","volume":"326","author":"Sweeney","year":"2006","journal-title":"Cell Tissue Res"},{"key":"10.1016\/j.jcmgh.2021.07.012_bib4","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1002\/(SICI)1096-8628(19980305)76:2<137::AID-AJMG6>3.0.CO;2-Q","article-title":"Prenatal diagnosis of autosomal recessive polycystic kidney disease (ARPKD): molecular genetics, clinical experience, and fetal morphology","volume":"76","author":"Zerres","year":"1998","journal-title":"Am J Med Genet"},{"key":"10.1016\/j.jcmgh.2021.07.012_bib5","first-page":"1101","article-title":"The severe perinatal form of autosomal recessive polycystic kidney disease maps to chromosome 6p21.1-p12: implications for genetic counseling","volume":"56","author":"Guay-Woodford","year":"1995","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.jcmgh.2021.07.012_bib6","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1007\/s004670050281","article-title":"Autosomal recessive polycystic kidney disease: long-term outcome of neonatal survivors","volume":"11","author":"Roy","year":"1997","journal-title":"Pediatr Nephrol"},{"key":"10.1016\/j.jcmgh.2021.07.012_bib7","doi-asserted-by":"crossref","first-page":"e833","DOI":"10.1542\/peds.2013-3646","article-title":"Autosomal recessive polycystic kidney disease: a hepatorenal fibrocystic disorder with pleiotropic effects","volume":"134","author":"Hartung","year":"2014","journal-title":"Pediatrics"},{"key":"10.1016\/j.jcmgh.2021.07.012_bib8","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1086\/340448","article-title":"PKHD1, the polycystic kidney and hepatic disease 1 gene, encodes a novel large protein containing multiple immunoglobulin-like plexin-transcription-factor domains and parallel beta-helix 1 repeats","volume":"70","author":"Onuchic","year":"2002","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.jcmgh.2021.07.012_bib9","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.ymgme.2003.10.010","article-title":"Molecular genetics of autosomal recessive polycystic kidney disease","volume":"81","author":"Harris","year":"2004","journal-title":"Mol Genet Metab"},{"key":"10.1016\/j.jcmgh.2021.07.012_bib10","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1111\/j.1523-1755.2004.00844.x","article-title":"Polyductin, the PKHD1 gene product, comprises isoforms expressed in plasma membrane, primary cilium, and cytoplasm","volume":"66","author":"Menezes","year":"2004","journal-title":"Kidney Int"},{"key":"10.1016\/j.jcmgh.2021.07.012_bib11","doi-asserted-by":"crossref","first-page":"5140","DOI":"10.3390\/ijms21145140","article-title":"Fibrocystin Is Essential to Cellular Control of Adhesion and Epithelial Morphogenesis","volume":"21","author":"Ziegler","year":"2020","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.jcmgh.2021.07.012_bib12","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1016\/S0272-6386(98)70072-1","article-title":"Cystic fibrosis and the phenotypic expression of autosomal dominant polycystic kidney disease","volume":"32","author":"O'Sullivan","year":"1998","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.jcmgh.2021.07.012_bib13","doi-asserted-by":"crossref","first-page":"2285","DOI":"10.1681\/ASN.V11122285","article-title":"CF gene and cystic fibrosis transmembrane conductance regulator expression in autosomal dominant polycystic kidney disease","volume":"11","author":"Persu","year":"2000","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.jcmgh.2021.07.012_bib14","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1681\/ASN.V124719","article-title":"Role of CFTR in autosomal recessive polycystic kidney disease","volume":"12","author":"Nakanishi","year":"2001","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.jcmgh.2021.07.012_bib15","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1007\/BF00864387","article-title":"Renal and biliary abnormalities in a new murine model of autosomal recessive polycystic kidney disease","volume":"7","author":"Nauta","year":"1993","journal-title":"Pediatr Nephrol"},{"key":"10.1016\/j.jcmgh.2021.07.012_bib16","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1055\/s-2007-1007159","article-title":"Liver and biliary problems in cystic fibrosis","volume":"18","author":"Colombo","year":"1998","journal-title":"Semin Liver Dis"},{"key":"10.1016\/j.jcmgh.2021.07.012_bib17","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1002\/j.2040-4603.2013.tb00495.x","article-title":"Physiology of cholangiocytes","volume":"3","author":"Tabibian","year":"2013","journal-title":"Compr Physiol"},{"issue":"Suppl 1","key":"10.1016\/j.jcmgh.2021.07.012_bib18","first-page":"S49","article-title":"Liver disease in cystic fibrosis","volume":"43","author":"Colombo","year":"2006","journal-title":"J\u00a0Pediatr Gastroenterol Nutr"},{"key":"10.1016\/j.jcmgh.2021.07.012_bib19","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1002\/hep.1840160215","article-title":"Bile-duct destruction and collagen deposition: a prominent ultrastructural feature of the liver in cystic fibrosis","volume":"16","author":"Lindblad","year":"1992","journal-title":"Hepatology"},{"key":"10.1016\/j.jcmgh.2021.07.012_bib20","doi-asserted-by":"crossref","first-page":"a004499","DOI":"10.1101\/cshperspect.a004499","article-title":"Emergent properties of proteostasis in managing cystic fibrosis","volume":"3","author":"Balch","year":"2011","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"10.1016\/j.jcmgh.2021.07.012_bib21","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/j.cell.2006.11.002","article-title":"CFTR: new members join the fold","volume":"127","author":"Skach","year":"2006","journal-title":"Cell"},{"key":"10.1016\/j.jcmgh.2021.07.012_bib22","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.ceb.2010.11.001","article-title":"Modeling general proteostasis: proteome balance in health and disease","volume":"23","author":"Roth","year":"2011","journal-title":"Curr Opin Cell Biol"},{"key":"10.1016\/j.jcmgh.2021.07.012_bib23","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1146\/annurev.physiol.64.081501.155819","article-title":"Molecular chaperones in the kidney","volume":"64","author":"Borkan","year":"2002","journal-title":"Annu Rev Physiol"},{"key":"10.1016\/j.jcmgh.2021.07.012_bib24","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1007\/s12192-009-0141-x","article-title":"Versatility of the small heat shock protein HSPB6 (Hsp20)","volume":"15","author":"Seit-Nebi","year":"2010","journal-title":"Cell Stress Chaperones"},{"key":"10.1016\/j.jcmgh.2021.07.012_bib25","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1038\/nrm2918","article-title":"HSP90 at the hub of protein homeostasis: emerging mechanistic insights","volume":"11","author":"Taipale","year":"2010","journal-title":"Nat Rev Mol Cell Biol"},{"key":"10.1016\/j.jcmgh.2021.07.012_bib26","doi-asserted-by":"crossref","first-page":"17073","DOI":"10.1074\/jbc.M117.797829","article-title":"A\u00a0chemical compound inhibiting the Aha1-Hsp90 chaperone complex","volume":"292","author":"Stiegler","year":"2017","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.jcmgh.2021.07.012_bib27","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1093\/carcin\/bgt111","article-title":"The HSP70 family and cancer","volume":"34","author":"Murphy","year":"2013","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.jcmgh.2021.07.012_bib28","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.4161\/cc.3.12.1287","article-title":"Heat shock protein 70 promotes cancer cell viability by safeguarding lysosomal integrity","volume":"3","author":"Gyrd-Hansen","year":"2004","journal-title":"Cell Cycle"},{"key":"10.1016\/j.jcmgh.2021.07.012_bib29","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1146\/annurev-biochem-060208-092442","article-title":"Molecular chaperone functions in protein folding and proteostasis","volume":"82","author":"Kim","year":"2013","journal-title":"Annu Rev Biochem"},{"key":"10.1016\/j.jcmgh.2021.07.012_bib30","doi-asserted-by":"crossref","first-page":"18843","DOI":"10.1073\/pnas.1105787108","article-title":"Correction of the F508del-CFTR protein processing defect in\u00a0vitro by the investigational drug VX-809","volume":"108","author":"Van Goor","year":"2011","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jcmgh.2021.07.012_bib31","doi-asserted-by":"crossref","first-page":"C389","DOI":"10.1152\/ajpcell.1996.270.1.C389","article-title":"A\u00a0role for CFTR in human autosomal dominant polycystic kidney disease","volume":"270","author":"Hanaoka","year":"1996","journal-title":"Am J Physiol"},{"key":"10.1016\/j.jcmgh.2021.07.012_bib32","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1681\/ASN.V1171179","article-title":"cAMP regulates cell proliferation and cyst formation in autosomal polycystic kidney disease cells","volume":"11","author":"Hanaoka","year":"2000","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.jcmgh.2021.07.012_bib33","doi-asserted-by":"crossref","first-page":"6447","DOI":"10.1021\/jm9009873","article-title":"Nanomolar potency pyrimido-pyrrolo-quinoxalinedione CFTR inhibitor reduces cyst size in a polycystic kidney disease model","volume":"52","author":"Tradtrantip","year":"2009","journal-title":"J\u00a0Med Chem"},{"key":"10.1016\/j.jcmgh.2021.07.012_bib34","doi-asserted-by":"crossref","first-page":"2235","DOI":"10.2174\/138161206777585148","article-title":"CFTR chloride channel drug discovery--inhibitors as antidiarrheals and activators for therapy of cystic fibrosis","volume":"12","author":"Verkman","year":"2006","journal-title":"Curr Pharm Des"},{"key":"10.1016\/j.jcmgh.2021.07.012_bib35","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1681\/ASN.2007070828","article-title":"Small-molecule CFTR inhibitors slow cyst growth in polycystic kidney disease","volume":"19","author":"Yang","year":"2008","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.jcmgh.2021.07.012_bib36","doi-asserted-by":"crossref","first-page":"203","DOI":"10.2165\/11313570-000000000-00000","article-title":"Therapeutic potential of cystic fibrosis transmembrane conductance regulator (CFTR) inhibitors in polycystic kidney disease","volume":"23","author":"Li","year":"2009","journal-title":"Biodrugs"},{"key":"10.1016\/j.jcmgh.2021.07.012_bib37","doi-asserted-by":"crossref","first-page":"17090","DOI":"10.1074\/jbc.RA119.010320","article-title":"Pharmacological reversal of renal cysts from secretion to absorption suggests a potential therapeutic strategy for managing autosomal dominant polycystic kidney disease","volume":"294","author":"Yanda","year":"2019","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.jcmgh.2021.07.012_bib38","doi-asserted-by":"crossref","first-page":"417","DOI":"10.2353\/ajpath.2008.070381","article-title":"Biliary and pancreatic dysgenesis in mice harboring a mutation in Pkhd1","volume":"172","author":"Gallagher","year":"2008","journal-title":"Am J Pathol"},{"key":"10.1016\/j.jcmgh.2021.07.012_bib39","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1016\/0092-8674(90)90148-8","article-title":"Defective intracellular transport and processing of CFTR is the molecular basis of most cystic fibrosis","volume":"63","author":"Cheng","year":"1990","journal-title":"Cell"},{"key":"10.1016\/j.jcmgh.2021.07.012_bib40","doi-asserted-by":"crossref","first-page":"6","DOI":"10.4103\/ijofb.ijofb_3_18","article-title":"Cytokeratin: A review on current concepts","volume":"2","author":"Kumar","year":"2018","journal-title":"Int J Orofac Biol"},{"key":"10.1016\/j.jcmgh.2021.07.012_bib41","first-page":"S93","article-title":"Mechanisms of progression in autosomal dominant polycystic kidney disease","volume":"63","author":"Grantham","year":"1997","journal-title":"Kidney Int Suppl"},{"key":"10.1016\/j.jcmgh.2021.07.012_bib42","first-page":"201","article-title":"Forskolin: a unique diterpene activator of cyclic AMP-generating systems","volume":"7","author":"Seamon","year":"1981","journal-title":"J\u00a0Cyclic Nucleotide Res"},{"key":"10.1016\/j.jcmgh.2021.07.012_bib43","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1021\/acsptsci.9b00060","article-title":"Emerging cystic fibrosis transmembrane conductance regulator modulators as new drugs for cystic fibrosis: a portrait of in\u00a0vitro pharmacology and clinical translation","volume":"3","author":"Ghelani","year":"2019","journal-title":"ACS Pharmacol Transl Sci"},{"key":"10.1016\/j.jcmgh.2021.07.012_bib44","doi-asserted-by":"crossref","first-page":"G961","DOI":"10.1152\/ajpgi.00030.2012","article-title":"Pancreatic and biliary secretion are both altered in cystic fibrosis pigs","volume":"303","author":"Uc","year":"2012","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"10.1016\/j.jcmgh.2021.07.012_bib45","doi-asserted-by":"crossref","first-page":"2792","DOI":"10.1158\/1078-0432.CCR-09-3112","article-title":"New molecular and biological mechanism of antitumor activities of KW\u20132478, a novel nonansamycin heat shock protein 90 inhibitor, in multiple myeloma cells","volume":"16","author":"Nakashima","year":"2010","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.jcmgh.2021.07.012_bib46","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1177\/1535370214527899","article-title":"VER\u2013155008, a small molecule inhibitor of HSP70 with potent anti-cancer activity on lung cancer cell lines","volume":"239","author":"Wen","year":"2014","journal-title":"Exp Biol Med (Maywood)"},{"key":"10.1016\/j.jcmgh.2021.07.012_bib47","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3001868","article-title":"The DeltaF508 mutation causes CFTR misprocessing and cystic fibrosis-like disease in pigs","volume":"3","author":"Ostedgaard","year":"2011","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.jcmgh.2021.07.012_bib48","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1042\/BJ20061890","article-title":"The protective and destructive roles played by molecular chaperones during ERAD (endoplasmic-reticulum-associated degradation)","volume":"404","author":"Brodsky","year":"2007","journal-title":"Biochem J"},{"key":"10.1016\/j.jcmgh.2021.07.012_bib49","doi-asserted-by":"crossref","first-page":"11513","DOI":"10.1074\/jbc.RA118.001846","article-title":"A\u00a0potential strategy for reducing cysts in autosomal dominant polycystic kidney disease with a CFTR corrector","volume":"293","author":"Yanda","year":"2018","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.jcmgh.2021.07.012_bib50","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1152\/physrev.00023.2010","article-title":"Large potentials of small heat shock proteins","volume":"91","author":"Mymrikov","year":"2011","journal-title":"Physiol Rev"},{"key":"10.1016\/j.jcmgh.2021.07.012_bib51","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1158\/1535-7163.MCT-06-0417","article-title":"Hsp27 knockdown using nucleotide-based therapies inhibit tumor growth and enhance chemotherapy in human bladder cancer cells","volume":"6","author":"Kamada","year":"2007","journal-title":"Mol Cancer Ther"},{"key":"10.1016\/j.jcmgh.2021.07.012_bib52","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.bbadis.2013.11.011","article-title":"Pro-inflammatory cytokines downregulate Hsp27 and cause apoptosis of human retinal capillary endothelial cells","volume":"1842","author":"Nahomi","year":"2014","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.jcmgh.2021.07.012_bib53","doi-asserted-by":"crossref","first-page":"25636","DOI":"10.1074\/jbc.M115.671925","article-title":"Combination of Correctors Rescue DeltaF508-CFTR by Reducing Its Association with Hsp40 and Hsp27","volume":"290","author":"Lopes-Pacheco","year":"2015","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.jcmgh.2021.07.012_bib54","doi-asserted-by":"crossref","first-page":"19743","DOI":"10.1074\/jbc.M115.647685","article-title":"Rescuing Trafficking Mutants of the ATP-binding Cassette Protein, ABCA4, with Small Molecule Correctors as a Treatment for Stargardt Eye Disease","volume":"290","author":"Sabirzhanova","year":"2015","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.jcmgh.2021.07.012_bib55","doi-asserted-by":"crossref","first-page":"G120","DOI":"10.1152\/ajpgi.00166.2019","article-title":"A\u00a0new role for heat shock factor 27 in the pathophysiology of Clostridium difficile toxin B","volume":"318","author":"Yanda","year":"2020","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"10.1016\/j.jcmgh.2021.07.012_bib56","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1111\/j.1749-6632.2010.05191.x","article-title":"HSPB1, actin filament dynamics, and aging cells","volume":"1197","author":"Doshi","year":"2010","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.jcmgh.2021.07.012_bib57","doi-asserted-by":"crossref","first-page":"4398","DOI":"10.1091\/mbc.e04-11-1019","article-title":"Inhibition of Pkhd1 impairs tubulomorphogenesis of cultured IMCD cells","volume":"16","author":"Mai","year":"2005","journal-title":"Mol Biol Cell"},{"key":"10.1016\/j.jcmgh.2021.07.012_bib58","author":"Proia"},{"key":"10.1016\/j.jcmgh.2021.07.012_bib59","doi-asserted-by":"crossref","first-page":"12786","DOI":"10.1073\/pnas.1301904110","article-title":"Inhibiting the HSP90 chaperone slows cyst growth in a mouse model of autosomal dominant polycystic kidney disease","volume":"110","author":"Seeger-Nukpezah","year":"2013","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jcmgh.2021.07.012_bib60","series-title":"Cystic Fibrosis","first-page":"299","article-title":"Hepatobiliary Involvement in Cystic Fibrosis","author":"Bertolini","year":"2020"},{"key":"10.1016\/j.jcmgh.2021.07.012_bib61","doi-asserted-by":"crossref","first-page":"jcs226886","DOI":"10.1242\/jcs.226886","article-title":"Transcytosis maintains CFTR apical polarity in the face of constitutive and mutation-induced basolateral missorting","volume":"132","author":"Bidaud-Meynard","year":"2019","journal-title":"J\u00a0Cell Sci"},{"key":"10.1016\/j.jcmgh.2021.07.012_bib62","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1038\/ki.2013.418","article-title":"Anoctamin 1 induces calcium-activated chloride secretion and proliferation of renal cyst\u2013forming epithelial cells","volume":"85","author":"Buchholz","year":"2014","journal-title":"Kidney Int"},{"key":"10.1016\/j.jcmgh.2021.07.012_bib63","doi-asserted-by":"crossref","first-page":"C267","DOI":"10.1152\/ajpcell.1992.263.2.C267","volume":"263","author":"Fuller","year":"1992","journal-title":"CFTR! Am J Physiol"},{"key":"10.1016\/j.jcmgh.2021.07.012_bib64","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1046\/j.1523-1755.2000.00921.x","article-title":"Defects in processing and trafficking of the cystic fibrosis transmembrane conductance regulator","volume":"57","author":"Skach","year":"2000","journal-title":"Kidney Int"},{"key":"10.1016\/j.jcmgh.2021.07.012_bib65","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/S2213-2600(16)30121-7","article-title":"Efficacy and safety of lumacaftor\/ivacaftor combination therapy in patients with cystic fibrosis homozygous for\u00a0Phe508del CFTR by pulmonary function subgroup: a pooled analysis","volume":"4","author":"Elborn","year":"2016","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.jcmgh.2021.07.012_bib66","doi-asserted-by":"crossref","first-page":"1940","DOI":"10.1093\/hmg\/ddm141","article-title":"Genetic interaction studies link autosomal dominant and recessive polycystic kidney disease in a common pathway","volume":"16","author":"Garcia-Gonzalez","year":"2007","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.jcmgh.2021.07.012_bib67","doi-asserted-by":"crossref","first-page":"17897","DOI":"10.1074\/jbc.M117.803775","article-title":"Histone deacetylase 6 inhibition reduces cysts by decreasing cAMP and Ca(2+) in knock-out mouse models of polycystic kidney disease","volume":"292","author":"Yanda","year":"2017","journal-title":"J\u00a0Biol Chem"}],"container-title":["Cellular and Molecular Gastroenterology and Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352345X21001582?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352345X21001582?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T18:28:46Z","timestamp":1762453726000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2352345X21001582"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021]]},"references-count":67,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2021]]}},"alternative-id":["S2352345X21001582"],"URL":"https:\/\/doi.org\/10.1016\/j.jcmgh.2021.07.012","relation":{},"ISSN":["2352-345X"],"issn-type":[{"value":"2352-345X","type":"print"}],"subject":[],"published":{"date-parts":[[2021]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Therapeutic Potential for CFTR Correctors in Autosomal Recessive Polycystic Kidney Disease","name":"articletitle","label":"Article Title"},{"value":"Cellular and Molecular Gastroenterology and Hepatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcmgh.2021.07.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Authors. Published by Elsevier Inc. on behalf of the AGA Institute.","name":"copyright","label":"Copyright"}]}}